Navigation Links
Repligen Announces Conference Call of First Quarter Fiscal Year 2011 Results
Date:7/26/2010

materially from those anticipated, including, without limitation, risks associated with: the success of current and future collaborative relationships; the market acceptance of our products; our ability to compete with larger, better financed pharmaceutical and biotechnology companies; new approaches to the treatment of our targeted diseases; our expectation of incurring continued losses; our uncertainty of product revenues and profits; our ability to generate future revenues; our ability to raise additional capital to continue our drug development programs; the success of our clinical trials; our ability to develop and commercialize products; our ability to obtain required regulatory approvals; our compliance with all Food and Drug Administration regulations; our ability to obtain; maintain and protect intellectual property rights for our products; the risk of litigation regarding our intellectual property rights; our limited sales and manufacturing capabilities; our dependence on third-party manufacturers and value added resellers; our ability to hire and retain skilled personnel; our volatile stock price; and other risks detailed in Repligen's annual report on Form 10-K on file with the Securities and Exchange Commission and the other reports that Repligen periodically files with the Securities and Exchange Commission. Actual results may differ materially from those Repligen contemplated by these forward-looking statements. These forward looking statements reflect management's current views and Repligen does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date hereof except as required by law.


'/>"/>
SOURCE Repligen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Repligen Reports Notice of Allowance of a United States Patent Covering the Use of Uridine to Treat the Symptoms of Bipolar Disorder
2. Repligen Receives Notice of Allowance for Recombinant Protein A Patent
3. Repligen Announces Long Term Supply Agreement with GE Healthcare for Recombinant Protein A
4. Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
5. Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
6. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
7. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
8. Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder
9. Abviva Announces Notice of Canadian Patent for Technology Used in Breast Cancer Diagnostics and Therapeutics
10. Perrigo Announces FDA Approval for Over-the-Counter Cetirizine Cherry Syrup
11. QPS Announces the Acquisition of Xendo Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... and BETHESDA, Md. , March 3, ... the first stem cell-derived islet replacement therapy for the ... presentation by Dr. Eugene Brandon , Director of ... Summit.  The annual summit showcases the latest in type ... of the presentation are as follows: , ...
(Date:3/3/2015)... MOUNTAIN VIEW, Calif. , March 3, 2015 ... the enhanced drug discovery market, Frost & Sullivan ... Frost & Sullivan Award for Technology Leadership. Neopeutics ... offering clients a robust, cost-effective, and easily adaptable ... on agents that are catalogued as failing compounds ...
(Date:3/3/2015)...  Cannabis Science, Inc. (OTCQB: CBIS), a U.S. company ... two important developments: It launched its toll-free call center ... CEO Raymond C. Dabney recently shared his ... In the article, Dabney answers questions from columnist ... an industry that is too new for a blueprint. ...
Breaking Medicine Technology:ViaCyte to Present at JDRF TypeOneNation Research Summit 2Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 2Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 3Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 4Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 5CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 3CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 4CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 5
... Needle by BellaNovus Development Company LLC, a medical ... is the latest in a growing list of physicians ... cosmetic injections. Dr. Busso is on the forefront of ... from cosmetic injections. Ouchless ® Needle is a ...
... 23, 2012 BACDT and Denture Professionals member ... to Uganda to help set up a prosthetic dental laboratory ... The trip has been arranged by Dentaid and ... have worked with a Clinical Dental Technician (CDT), however both ...
Cached Medicine Technology:New Ouchless® Needle Collection Announces Leading Dermatology Testimonial 2BACDT Member Mark Melbourne off to Uganda With Dentaid and Christian Relief 2
(Date:3/3/2015)... While it is clear that the ... young Canadian drivers are signing up to UBI policies, ... to be enticed. Due to current regulations, the application ... form. Its full capability is starting to be ... maintenance, emergency breakdown services are at the top of ...
(Date:3/3/2015)... Today is International Ear Care Day, and the ... applaud and promote the launch of Make Listening Safe, ... for stemming the threat of noise-induced hearing loss. , ... practice safe listening when they recreate, be that listening ... or engaging in other forms of entertainment. , ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 The Calistoga Chamber ... “Mudder of All Weekends,” taking place Friday, March 27, through ... hunt, Pretty Muddy 5K fun run, restaurant and bar crawl, ... is open to women, ages 14 and older. , A ... are getting in on the action by offering Mudder of ...
(Date:3/3/2015)... Ann Arbor, MI (PRWEB) March 03, 2015 ... on NPR News Morning Edition, science correspondent Shankar Vedantam ... the University of Pennsylvania about the drastic decrease in hand-hygiene ... shift. He suggested that the problem could be solved in ... to perform hand hygiene when they enter and exit a ...
(Date:3/3/2015)... 2015 OncLive® and Indiana University ... forces to share news about the center’s research ... is part of OncLive’s Strategic Alliance Partnership initiative. ... and marketing teams will partner with the IU ... center, to highlight accomplishments. They include the center’s ...
Breaking Medicine News(10 mins):Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:ASHA Applauds Launch of New WHO Campaign 2Health News:Visit Calistoga Hosts Mudder of All Weekends Girlfriend Getaway Event 2Health News:Visit Calistoga Hosts Mudder of All Weekends Girlfriend Getaway Event 3Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 2Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 3Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 3
... Institute for Evolutionary Anthropology, Leipzig, Germany, have investigated evidence ... ,Debates about altruism are often based on the assumption ... the human version differs from that of other animals ... and colleagues have found evidence that chimpanzees act altruistically ...
... that smoking may hamper alcoholics neurocognitive recovery during their first ... ,About 50 to 90 percent of individuals in ... new findings show that smoking may interfere with the neurocognitive ... months of abstinence from alcohol. ,The results ...
... annual UN report on illegal drugs has said that opium ... ,The World Drug Report says over 90 percent of ... Afghanistan. ,According to a BBC report, the ... the presence of more than 30,000 international troops there, and ...
... have discovered that attaching polymeric nanoparticles to the ... in vivo lifetime of the nanoparticles. ... drugs. They protect drugs from degradation until they ... drugs. Polymeric nanoparticles, however, suffer from one major ...
... The Kenyan governmment said Tuesday the rate of HIV/AIDS infections had ... major challenge in the country. ,The state-run National ... in 2004 to the current 5.9 percent of the country's nearly ... in new infections from 85,000 in 2004 to 60,000 in 2005 ...
... in the egg cells of the Northern Leopard frog (Rana ... for brain tumours. ,The molecule Amphinase,recognises the ... its surface before invading the cell and inactivating the RNA ... new research published in the Journal of Molecular Biology, scientists ...
Cached Medicine News:Health News:Smoking Hampers Alcoholics' Neurocognitive Recovery During Abstinence 2Health News:Smoking Hampers Alcoholics' Neurocognitive Recovery During Abstinence 3Health News:Adherence of Nanoparticles to RBC- Very Effective Drug Delivery Method 2Health News:Brain Tumor Drug in Frogs A New Report 2
This product is for the lower body and uses a Convective Warming System which is both soft and comfortable. Constructed of 2-ply material consisting of polyethylene film inner layer and non-woven out...
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
CritiCool™ offers precise cooling to the programmed target temperature by applying temperature control algorithm....
Medicine Products: